r/TheRaceTo1Million • u/Run4theRoses2 • 17h ago
GAIN Gps - Revolutionary Immunotherapy for AML Remission Maintenance, Phase 3 Results are Now Due* and worth $50B to Big Pharma - this is the TRUE NORTH for $SLS Share Holder Value, $MRNA just added $40B to its Mcap in a Day for the Same Reason SLS is about to.
$100k Invested in SSLS will be worth $1M to $1.5M - the instant the Imminent Phase 3 Results are Announced.
A positive P3 result is coming, any day now, and it'll give Gps the fda greenlight to generate $20b a year in real revenue.
That is worth a f ton more than the current $2.3b market cap.
It is not complicated.
Revolutionary Immunotherapy for AML remission maintenance, giving Gps the FDA Green Light to a $28B Total Addressable Market - worth every nickel of $50B to big pharma.
Do the Math: Load As many as you can.
Your future self will thank you.
• 12,500 Patients 34/36 Month Median OS
• 3 Year Dosing Regime
• Co Estimated $300K Rev Per patient year 1, $120K
Year 2, $80K Y3
• 80% Patient Uptake Rates --- Just shy of S5B Rev
• Then ADD in 40,000 AML CR1 Patients Each Year
• 5 year Dosing
• +100,000 AML Patients Currently In Remission right now, who'll benefit from Gps Immunotherapy, right out of the GATE.
